May 15, 2017 20:02 pm UTC| Business
DALLAS, May 15, 2017 -- Capital Southwest Corporation (“Capital Southwest” or the “Company”) (Nasdaq:CSWC) announced today that it will release its fourth quarter and Fiscal Year 2017 results on Wednesday, May 31, 2017,...
Cumulus Reports Operating Results for First Quarter 2017
May 15, 2017 20:02 pm UTC| Business
ATLANTA, May 15, 2017 -- Cumulus Media Inc. (NASDAQ:CMLS) (the “Company,” “we,” “us,” or “our”) today announced operating results for the three months ended March31, 2017. For the three months ended March31, 2017,...
Cumulus Reports Operating Results for First Quarter 2017
May 15, 2017 20:02 pm UTC| Business
ATLANTA, May 15, 2017 -- Cumulus Media Inc. (NASDAQ:CMLS) (the “Company,” “we,” “us,” or “our”) today announced operating results for the three months ended March31, 2017. For the three months ended March31, 2017,...
CytomX Announces Management Team Changes
May 15, 2017 20:02 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., May 15, 2017 -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, today announced that Bob...
CytomX Announces Management Team Changes
May 15, 2017 20:02 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., May 15, 2017 -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, today announced that Bob...
Editas Medicine Announces First Quarter 2017 Results and Update
May 15, 2017 20:02 pm UTC| Business
Entered strategic RD alliance with ophthalmology leader Allergan to develop and commercialize ground-breaking medicines for patients with serious eye diseases Completed successful follow-on offering of common stock...
Editas Medicine Announces First Quarter 2017 Results and Update
May 15, 2017 20:02 pm UTC| Business
Entered strategic RD alliance with ophthalmology leader Allergan to develop and commercialize ground-breaking medicines for patients with serious eye diseases Completed successful follow-on offering of common stock...